BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25861031)

  • 1. Survival after locoregional recurrence or second primary breast cancer: impact of the disease-free interval.
    Witteveen A; Kwast AB; Sonke GS; IJzerman MJ; Siesling S
    PLoS One; 2015; 10(4):e0120832. PubMed ID: 25861031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locoregional recurrence after breast-conserving therapy remains an independent prognostic factor even after an event free interval of 10 years in early stage breast cancer.
    Tanis E; van de Velde CJ; Bartelink H; van de Vijver MJ; Putter H; van der Hage JA
    Eur J Cancer; 2012 Aug; 48(12):1751-6. PubMed ID: 22446021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome of isolated locoregional recurrence in patients with breast cancer according to their primary local treatment.
    Shenouda MN; Sadek BT; Goldberg SI; Keruakous AR; Croft BJ; Abi Raad RF; Taghian AG
    Clin Breast Cancer; 2014 Jun; 14(3):198-204. PubMed ID: 24485702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research.
    Borner M; Bacchi M; Goldhirsch A; Greiner R; Harder F; Castiglione M; Jungi WF; Thürlimann B; Cavalli F; Obrecht JP
    J Clin Oncol; 1994 Oct; 12(10):2071-7. PubMed ID: 7931476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT; Yong CM; Abnousi F; Lee J; Kader HA; Hayashi A; Olivotto IA
    J Am Coll Surg; 2005 Jun; 200(6):912-21. PubMed ID: 15922205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of apex axillary invasion for locoregional recurrence and effect of postmastectomy radiotherapy on overall survival in node-positive breast cancer patients.
    Kuru B; Camlibel M; Dinc S; Gulcelik MA; Alagol H
    World J Surg; 2004 Mar; 28(3):236-41. PubMed ID: 14961194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for locoregional recurrence and survival in stage IIIC breast carcinoma: impact of adjuvant radiotherapy.
    Kuru B
    Singapore Med J; 2011 Apr; 52(4):289-98. PubMed ID: 21552792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Akashi-Tanaka S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Cancer; 2006 Jan; 106(1):35-41. PubMed ID: 16333848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and radiotherapy following neoadjuvant chemotherapy.
    Min SY; Lee SJ; Shin KH; Park IH; Jung SY; Lee KS; Ro J; Lee S; Kim SW; Kim TH; Kang HS; Cho KH
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e697-705. PubMed ID: 21129858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer.
    Gabos Z; Thoms J; Ghosh S; Hanson J; Deschênes J; Sabri S; Abdulkarim B
    Breast Cancer Res Treat; 2010 Nov; 124(1):187-94. PubMed ID: 20814819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Factors of Survival among Women with Metastatic Breast Cancer and Impact of Primary or Secondary Nature of Disease on Survival: A French Population-Based Study.
    Marshall EM; Bertaut A; Desmoulins I; Darut-Jouve A; Ponnelle T; Poillot ML; Beltjens F; Arveux P
    Breast J; 2017 Mar; 23(2):138-145. PubMed ID: 27935232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body Mass Index and Locoregional Recurrence in Women with Early-Stage Breast Cancer.
    Warren LE; Ligibel JA; Chen YH; Truong L; Catalano PJ; Bellon JR
    Ann Surg Oncol; 2016 Nov; 23(12):3870-3879. PubMed ID: 27448118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Cure Rates for Breast Cancer Improved by Local and Regional Anesthesia?
    Tsigonis AM; Al-Hamadani M; Linebarger JH; Vang CA; Krause FJ; Johnson JM; Marchese E; Marcou KA; Hudak JM; Landercasper J
    Reg Anesth Pain Med; 2016; 41(3):339-47. PubMed ID: 26928797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.
    Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pN0(i+) breast cancer: treatment patterns, locoregional recurrence, and survival outcomes.
    Karam I; Lesperance MF; Berrang T; Speers C; Tyldesley S; Truong PT
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):731-7. PubMed ID: 24035330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments.
    Yu JI; Park W; Choi DH; Huh SJ; Nam SJ; Kim SW; Lee JE; Kil WH; Im YH; Ahn JS; Park YH; Cho EY
    Clin Breast Cancer; 2015 Dec; 15(6):512-8. PubMed ID: 26188791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of internal mammary node irradiation on long-term outcome and contralateral breast cancer incidence in node-negative breast cancer patients.
    Courdi A; Chamorey E; Ferrero JM; Hannoun-Lévi JM
    Radiother Oncol; 2013 Aug; 108(2):259-65. PubMed ID: 23891092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment.
    Jwa E; Shin KH; Kim JY; Park YH; Jung SY; Lee ES; Park IH; Lee KS; Ro J; Kim YJ; Kim TH
    Cancer Res Treat; 2016 Oct; 48(4):1363-1372. PubMed ID: 26910473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in patients with breast cancer with bone metastasis: a Danish population-based cohort study on the prognostic impact of initial stage of disease at breast cancer diagnosis and length of the bone metastasis-free interval.
    Cetin K; Christiansen CF; Sværke C; Jacobsen JB; Sørensen HT
    BMJ Open; 2015 Apr; 5(4):e007702. PubMed ID: 25926150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.